Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bevacizumab can improve the outcome of
treatment for patients with esophageal cancer whose disease is confined to the esophagus or
the closely surrounding lymph nodes.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center